EHPM Leadership Continuity: Santoro's Role and Implications for European Supplement Oversight
Dr. Antonino Santoro continues his pivotal role as EHPM Chair, bringing extensive experience from both regulatory affairs and product development within the pharma and nutraceutical sectors. His leadership signals stability and continued focus on compliance and innovation for the European supplement industry.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
EHPM Chair Dr. Santoro: A Steady Hand in European Supplement Regulation
For manufacturers like us and brand owners operating within the dynamic European nutraceutical market, understanding the leadership within key industry bodies is paramount. The continued tenure of Dr. Antonino Santoro as Chair of the European Federation of Associations of Health Product Manufacturers (EHPM) provides a crucial reference point. Dr. Santoro's background paints a clear picture of the expertise guiding EHPM's influence on European food supplement policy and standards.
Graduating in Chemistry from the University of Messina, Dr. Santoro’s career trajectory has embedded him deeply within both the research and regulatory facets of the health product sector. His significant experience includes roles in regulatory affairs and business development at Rottapharm/Madaus, a prominent international entity in medicinal products, food supplements, medical devices, and cosmetics. This dual perspective is invaluable – understanding both the scientific grounding of product development and the intricate pathways required for market approval and compliance. From a formulation standpoint, this suggests an emphasis from EHPM on robust scientific substantiation alongside adherence to established regulatory frameworks.
Furthermore, Dr. Santoro's academic contributions, including teaching Regulatory Affairs at the University of Pavia, authoring scientific publications, and holding patents, underscore a commitment to scientific rigour. This academic grounding ensures that EHPM’s positions on ingredient efficacy, safety, and allowable claims are informed by current scientific understanding, a critical factor for manufacturers developing innovative products.
What Santoro's Leadership Means for the Industry
“The ongoing presence of experienced leaders like Dr. Santoro in pivotal roles within organisations such as EHPM offers a degree of predictability in an otherwise rapidly evolving regulatory environment. For contract manufacturers, this means clearer signals regarding future compliance requirements.” — Supplement Factory Editorial Team
Having been a board member of FederSalus (now Integratori & Salute) since 2005, and as Vice-President for several years, Dr. Santoro brings a wealth of experience in national industry representation – something vital for EHPM’s pan-European mandate. His continuous involvement with EHPM since joining its board in March 2013, culminating in his chairmanship since February 2021, demonstrates consistent leadership. Brand owners should note that this continuity is likely to foster a stable and well-informed advocate for the supplement industry in discussions with European regulatory bodies.
In essence, Dr. Santoro’s leadership at EHPM reinforces the emphasis on science-backed products, stringent regulatory compliance, and a harmonised approach across Europe. This is welcome news for contract manufacturers seeking clarity and brand owners aiming to build consumer trust through high-quality, compliant food supplements.
Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.